HEADER IMMUNE SYSTEM 02-NOV-17 6BIN TITLE HLA-DRB1 IN COMPLEX WITH TYPE II COLLAGEN PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MHC CLASS II ANTIGEN DRA; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: TYPE II COLLAGEN 1240CIT 1237-1249; COMPND 8 CHAIN: C; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DRB1-4 BETA CHAIN; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: MHC CLASS II ANTIGEN DRB1*4,DR4; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-DRA, HLA-DRA1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI-; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI-; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: HLA-DRB1; SOURCE 20 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 22 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI- KEYWDS HLA, MHC, CITRULLINE, RHEUMATOID ARTHRITIS, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR Y.T.TING,S.W.SCALLY,J.ROSSJOHN REVDAT 6 15-NOV-23 6BIN 1 LINK ATOM REVDAT 5 04-OCT-23 6BIN 1 HETSYN REVDAT 4 29-JUL-20 6BIN 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 14-MAR-18 6BIN 1 JRNL REVDAT 2 24-JAN-18 6BIN 1 TITLE JRNL REVDAT 1 17-JAN-18 6BIN 0 JRNL AUTH Y.T.TING,J.PETERSEN,S.H.RAMARATHINAM,S.W.SCALLY,K.L.LOH, JRNL AUTH 2 R.THOMAS,A.SURI,D.G.BAKER,A.W.PURCELL,H.H.REID,J.ROSSJOHN JRNL TITL THE INTERPLAY BETWEEN CITRULLINATION AND HLA-DRB1 JRNL TITL 2 POLYMORPHISM IN SHAPING PEPTIDE BINDING HIERARCHIES IN JRNL TITL 3 RHEUMATOID ARTHRITIS. JRNL REF J. BIOL. CHEM. V. 293 3236 2018 JRNL REFN ESSN 1083-351X JRNL PMID 29317506 JRNL DOI 10.1074/JBC.RA117.001013 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.336 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 16976 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.243 REMARK 3 FREE R VALUE TEST SET COUNT : 890 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.4743 - 4.5409 1.00 2803 163 0.1742 0.1962 REMARK 3 2 4.5409 - 3.6050 1.00 2691 146 0.1795 0.2071 REMARK 3 3 3.6050 - 3.1495 1.00 2674 152 0.2016 0.2528 REMARK 3 4 3.1495 - 2.8617 1.00 2628 150 0.2287 0.2763 REMARK 3 5 2.8617 - 2.6566 1.00 2659 147 0.2378 0.2750 REMARK 3 6 2.6566 - 2.5000 1.00 2631 132 0.2473 0.3142 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.302 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.658 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3244 REMARK 3 ANGLE : 0.547 4408 REMARK 3 CHIRALITY : 0.043 478 REMARK 3 PLANARITY : 0.004 570 REMARK 3 DIHEDRAL : 15.847 1906 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BIN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1000230926. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-OCT-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : KYLIN REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16976 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 39.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4MDI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22-28% PEG 3350, 0.2M POTASSIUM REMARK 280 NITRATE, 0.1M BIS-TRIS-PROPANE PH 7.3, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.59500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.59500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.67500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 91.85500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.67500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 91.85500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 38.59500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.67500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 91.85500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 38.59500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.67500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 91.85500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 1 REMARK 465 LYS A 2 REMARK 465 THR A 182 REMARK 465 SER A 183 REMARK 465 GLY A 184 REMARK 465 ASP A 185 REMARK 465 ASP A 186 REMARK 465 ASP A 187 REMARK 465 ASP A 188 REMARK 465 LYS A 189 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 GLY B 1 REMARK 465 THR B 191 REMARK 465 GLY B 192 REMARK 465 GLY B 193 REMARK 465 ASP B 194 REMARK 465 ASP B 195 REMARK 465 ASP B 196 REMARK 465 ASP B 197 REMARK 465 LYS B 198 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 ARG B 23 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 52 CG CD OE1 OE2 REMARK 470 GLU B 69 CG CD OE1 OE2 REMARK 470 GLU B 98 CG CD OE1 OE2 REMARK 470 GLN B 107 CG CD OE1 NE2 REMARK 470 LEU B 109 CG CD1 CD2 REMARK 470 GLN B 110 CG CD OE1 NE2 REMARK 470 HIS B 111 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 136 CG CD OE1 NE2 REMARK 470 ARG B 189 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET C 3 CA - C - N ANGL. DEV. = -14.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 19 76.88 51.11 REMARK 500 HIS B 33 -111.42 58.50 REMARK 500 TYR B 78 -52.39 -122.03 REMARK 500 THR B 90 -66.90 -123.27 REMARK 500 PRO B 108 83.61 -63.70 REMARK 500 PRO B 124 -166.45 -75.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 MET C 3 20.70 REMARK 500 CIR C 4 14.10 REMARK 500 REMARK 500 REMARK: NULL DBREF 6BIN A 5 181 UNP P01903 DRA_HUMAN 30 206 DBREF 6BIN C 1 13 PDB 6BIN 6BIN 1 13 DBREF 6BIN B 1 190 UNP P13760 2B14_HUMAN 30 219 SEQADV 6BIN ILE A 1 UNP P01903 EXPRESSION TAG SEQADV 6BIN LYS A 2 UNP P01903 EXPRESSION TAG SEQADV 6BIN GLU A 3 UNP P01903 EXPRESSION TAG SEQADV 6BIN GLU A 4 UNP P01903 EXPRESSION TAG SEQADV 6BIN THR A 182 UNP P01903 EXPRESSION TAG SEQADV 6BIN SER A 183 UNP P01903 EXPRESSION TAG SEQADV 6BIN GLY A 184 UNP P01903 EXPRESSION TAG SEQADV 6BIN ASP A 185 UNP P01903 EXPRESSION TAG SEQADV 6BIN ASP A 186 UNP P01903 EXPRESSION TAG SEQADV 6BIN ASP A 187 UNP P01903 EXPRESSION TAG SEQADV 6BIN ASP A 188 UNP P01903 EXPRESSION TAG SEQADV 6BIN LYS A 189 UNP P01903 EXPRESSION TAG SEQADV 6BIN GLY B -1 UNP P13760 EXPRESSION TAG SEQADV 6BIN SER B 0 UNP P13760 EXPRESSION TAG SEQADV 6BIN THR B 191 UNP P13760 EXPRESSION TAG SEQADV 6BIN GLY B 192 UNP P13760 EXPRESSION TAG SEQADV 6BIN GLY B 193 UNP P13760 EXPRESSION TAG SEQADV 6BIN ASP B 194 UNP P13760 EXPRESSION TAG SEQADV 6BIN ASP B 195 UNP P13760 EXPRESSION TAG SEQADV 6BIN ASP B 196 UNP P13760 EXPRESSION TAG SEQADV 6BIN ASP B 197 UNP P13760 EXPRESSION TAG SEQADV 6BIN LYS B 198 UNP P13760 EXPRESSION TAG SEQRES 1 A 189 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 A 189 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 A 189 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 A 189 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 A 189 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 A 189 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 A 189 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 A 189 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 A 189 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 A 189 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 A 189 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 A 189 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 A 189 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 A 189 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP THR SEQRES 15 A 189 SER GLY ASP ASP ASP ASP LYS SEQRES 1 C 13 GLN TYR MET CIR ALA ASP GLN ALA ALA GLY GLY LEU ARG SEQRES 1 B 200 GLY SER GLY ASP THR ARG PRO ARG PHE LEU GLU GLN VAL SEQRES 2 B 200 LYS HIS GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL SEQRES 3 B 200 ARG PHE LEU ASP ARG TYR PHE TYR HIS GLN GLU GLU TYR SEQRES 4 B 200 VAL ARG PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL SEQRES 5 B 200 THR GLU LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER SEQRES 6 B 200 GLN LYS ASP LEU LEU GLU GLN LYS ARG ALA ALA VAL ASP SEQRES 7 B 200 THR TYR CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE SEQRES 8 B 200 THR VAL GLN ARG ARG VAL TYR PRO GLU VAL THR VAL TYR SEQRES 9 B 200 PRO ALA LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU SEQRES 10 B 200 VAL CYS SER VAL ASN GLY PHE TYR PRO GLY SER ILE GLU SEQRES 11 B 200 VAL ARG TRP PHE ARG ASN GLY GLN GLU GLU LYS THR GLY SEQRES 12 B 200 VAL VAL SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR SEQRES 13 B 200 PHE GLN THR LEU VAL MET LEU GLU THR VAL PRO ARG SER SEQRES 14 B 200 GLY GLU VAL TYR THR CYS GLN VAL GLU HIS PRO SER LEU SEQRES 15 B 200 THR SER PRO LEU THR VAL GLU TRP ARG ALA THR GLY GLY SEQRES 16 B 200 ASP ASP ASP ASP LYS HET CIR C 4 11 HET NAG D 1 14 HET NAG D 2 14 HET NAG A 203 14 HET NAG B 201 14 HETNAM CIR CITRULLINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 CIR C6 H13 N3 O3 FORMUL 4 NAG 4(C8 H15 N O6) FORMUL 7 HOH *113(H2 O) HELIX 1 AA1 GLU A 47 ALA A 52 1 6 HELIX 2 AA2 ALA A 56 SER A 77 1 22 HELIX 3 AA3 THR B 51 LEU B 53 5 3 HELIX 4 AA4 GLY B 54 SER B 63 1 10 HELIX 5 AA5 GLN B 64 ALA B 73 1 10 HELIX 6 AA6 ALA B 73 TYR B 78 1 6 HELIX 7 AA7 TYR B 78 GLU B 87 1 10 SHEET 1 AA1 8 GLU A 40 TRP A 43 0 SHEET 2 AA1 8 ASP A 29 ASP A 35 -1 N HIS A 33 O VAL A 42 SHEET 3 AA1 8 SER A 19 PHE A 26 -1 N PHE A 26 O ASP A 29 SHEET 4 AA1 8 HIS A 5 ASN A 15 -1 N ILE A 8 O ASP A 25 SHEET 5 AA1 8 PHE B 7 PHE B 18 -1 O HIS B 13 N GLN A 9 SHEET 6 AA1 8 ARG B 23 TYR B 32 -1 O PHE B 31 N GLN B 10 SHEET 7 AA1 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 AA1 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AA2 4 GLU A 88 THR A 93 0 SHEET 2 AA2 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA2 4 PHE A 145 PHE A 153 -1 O LEU A 151 N LEU A 105 SHEET 4 AA2 4 SER A 133 GLU A 134 -1 N SER A 133 O TYR A 150 SHEET 1 AA3 4 GLU A 88 THR A 93 0 SHEET 2 AA3 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA3 4 PHE A 145 PHE A 153 -1 O LEU A 151 N LEU A 105 SHEET 4 AA3 4 LEU A 138 PRO A 139 -1 N LEU A 138 O ARG A 146 SHEET 1 AA4 4 LYS A 126 VAL A 128 0 SHEET 2 AA4 4 ASN A 118 ARG A 123 -1 N TRP A 121 O VAL A 128 SHEET 3 AA4 4 VAL A 160 GLU A 166 -1 O ARG A 164 N THR A 120 SHEET 4 AA4 4 LEU A 174 GLU A 179 -1 O TRP A 178 N TYR A 161 SHEET 1 AA5 4 GLU B 98 ALA B 104 0 SHEET 2 AA5 4 LEU B 114 PHE B 122 -1 O SER B 118 N THR B 100 SHEET 3 AA5 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 AA5 4 VAL B 142 SER B 144 -1 N VAL B 143 O MET B 160 SHEET 1 AA6 4 GLU B 98 ALA B 104 0 SHEET 2 AA6 4 LEU B 114 PHE B 122 -1 O SER B 118 N THR B 100 SHEET 3 AA6 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 AA6 4 ILE B 148 GLN B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 AA7 4 GLN B 136 GLU B 137 0 SHEET 2 AA7 4 GLU B 128 ARG B 133 -1 N ARG B 133 O GLN B 136 SHEET 3 AA7 4 VAL B 170 GLU B 176 -1 O GLN B 174 N ARG B 130 SHEET 4 AA7 4 LEU B 184 ARG B 189 -1 O TRP B 188 N TYR B 171 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.03 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.03 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.03 LINK ND2 ASN A 78 C1 NAG A 203 1555 1555 1.47 LINK ND2 ASN A 118 C1 NAG D 1 1555 1555 1.48 LINK C MET C 3 N CIR C 4 1555 1555 1.31 LINK C CIR C 4 N ALA C 5 1555 1555 1.31 LINK ND2 ASN B 19 C1 NAG B 201 1555 1555 1.57 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.49 CISPEP 1 ASN A 15 PRO A 16 0 -0.50 CISPEP 2 THR A 113 PRO A 114 0 -0.44 CISPEP 3 TYR B 123 PRO B 124 0 2.62 CRYST1 67.350 183.710 77.190 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014848 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005443 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012955 0.00000